Growth Metrics

Merck (MRK) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $18.2 billion.

  • Merck's Cash & Current Investments rose 2481.33% to $18.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 billion, marking a year-over-year increase of 2481.33%. This contributed to the annual value of $13.7 billion for FY2024, which is 9299.31% up from last year.
  • As of Q3 2025, Merck's Cash & Current Investments stood at $18.2 billion, which was up 2481.33% from $8.6 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Cash & Current Investments peaked at $18.2 billion during Q3 2025, and registered a low of $5.6 billion during Q1 2024.
  • Its 5-year average for Cash & Current Investments is $10.1 billion, with a median of $9.2 billion in 2025.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 4623.26% in 2023, then surged by 9299.31% in 2024.
  • Merck's Cash & Current Investments (Quarter) stood at $8.1 billion in 2021, then surged by 62.94% to $13.2 billion in 2022, then tumbled by 46.23% to $7.1 billion in 2023, then surged by 92.99% to $13.7 billion in 2024, then surged by 33.06% to $18.2 billion in 2025.
  • Its Cash & Current Investments was $18.2 billion in Q3 2025, compared to $8.6 billion in Q2 2025 and $9.2 billion in Q1 2025.